Biotech · Private company · Los Gatos, CA, US
Aridis Pharmaceuticals, Inc.
SEC CIK 0001614067
Track this companyFree. Adds Aridis Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- AR-105Phase 2 · Pseudomonas Aeruginosa PneumoniaClinicalTrials.gov · fetched Nov 12, 2026
- Inhaled AR-501Phase 2 · Cystic FibrosisClinicalTrials.gov · fetched Nov 12, 2026
- KBSA301Phase 2 · Pneumonia Due to Staphylococcus AureusClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- SAD and MAD of Inhaled AR-501 in Health Adults and P. Aeruginosa Infected Cystic Fibrosis SubjectsPHASE1_PHASE2 · UNKNOWN · started Dec 7, 2018ClinicalTrials.gov NCT03669614 · fetched Nov 12, 2026
- Adjunctive Therapeutic Treatment With Human Monoclonal Antibody AR-105 (Aerucin®) in P. Aeruginosa PneumoniaPHASE2 · COMPLETED · started Mar 29, 2017ClinicalTrials.gov NCT03027609 · fetched Nov 12, 2026
- Safety, Pharmacokinetics and Efficacy of KBSA301 in Severe Pneumonia (S. Aureus)PHASE1_PHASE2 · COMPLETED · started May 1, 2012ClinicalTrials.gov NCT01589185 · fetched Nov 12, 2026